1. Home
  2. WGS vs NEOG Comparison

WGS vs NEOG Comparison

Compare WGS & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$58.18

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Logo Neogen Corporation

NEOG

Neogen Corporation

HOLD

Current Price

$12.26

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WGS
NEOG
Founded
2017
1981
Country
United States
United States
Employees
N/A
1257
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.7B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
WGS
NEOG
Price
$58.18
$12.26
Analyst Decision
Strong Buy
Buy
Analyst Count
8
4
Target Price
★ $93.50
$14.00
AVG Volume (30 Days)
643.6K
★ 4.2M
Earning Date
11-03-2026
10-06-2026
Dividend Yield
N/A
N/A
EPS Growth
62.37
★ 99.20
EPS
N/A
★ N/A
Revenue
$427,539,000.00
★ $870,400,000.00
Revenue This Year
$12.70
$1.73
Revenue Next Year
$24.31
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 39.97
N/A
52 Week Low
$32.21
$5.37
52 Week High
$170.87
$14.26

Technical Indicators

Market Signals
Indicator
WGS
NEOG
Relative Strength Index (RSI) 32.45 51.47
Support Level $56.36 $11.25
Resistance Level $73.04 $12.52
Average True Range (ATR) 5.31 0.64
MACD -0.35 -0.02
Stochastic Oscillator 8.86 52.79

Price Performance

Historical Comparison
WGS
NEOG

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

About NEOG Neogen Corporation

Neogen Corp is develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Its Food Safety segment consists mainly of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. These products also ensure the general hygiene of the food manufacturing environment. It also have products to determine food quality and nutritional components. Its segments are Food, Animal safety. Majority of revenue comes from Food Safety. It has presence in United states, and International market.

Share on Social Networks: